Granulocytes exhibit abundant expression of Anxa1, which exerts protective effects through paracrine or autocrine signalling, and Anxa1 is upregulated with NAFLD progression (41). Here, ANXA1 is linked to metabolic dysfunction-associated steatotic liver disease.